#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Anti-Escherichia coli asparaginase antibody levels determine the activity of second-line treatment with pegylated E. coli asparaginase: a retrospective analysis within the ALL-BFM trials


Authors: O. Hrodek
Published in: Transfuze Hematol. dnes,18, 2012, No. 1, p. 47.
Category: Selection of press reports and books


Labels
Haematology Internal medicine Clinical oncology

Article was published in

Transfusion and Haematology Today

Issue 1

2012 Issue 1

Most read in this issue
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#